Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

This publication has 36 references indexed in Scilit:

• Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
  Journal of Clinical Investigation, 2001
• Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells
  Life Sciences, 2000
• Not Acute but Chronic Hypertriglyceridemia Is Associated With Impaired Endothelium-Dependent Vasodilation
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Inhibition of proinflammatory cytokine production by pravastatin
  The Lancet, 1999
• The PPARα–leukotriene B4 pathway to inflammation control
  Nature, 1996
• High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• HDL, its enzymes and its potential to influence lipid peroxidation
  Atherosclerosis, 1995
• Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion
  Blood Coagulation & Fibrinolysis, 1993
• Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis
  Diabetes Care, 1991